VaDDRx: Emerging Targets, Techniques, and Therapeutics for Cancer and Neuroscience

May 21 – 22, 2019        Hotel Roanoke

Roanoke, VA



Keynote speakers

Susan Amara

Scientific Director, National Institute of Mental Health, Bethesda, MD 20892

Talk: “Dynamic Regulation of Signaling in Dopamine Neurons: New Pathways for Neuropsychiatric Drug Discovery”

Laura M. Bohn

Professor, Department of Molecular Medicine, The Scripps Research Institute

Talk: “Harnessing Opiod Receptor Function to Improve Physiological Responses”

Susan Horwitz

Falkenstein Chair in Cancer Research, Department of Molecular Pharmacology, Albert Einstein College of Medicine

Talk: “Taxol, Tubulin, and Tumors: A Story of Drug Development”

Special Note: Susan Band Horwitz, Ph.D., has been named one of seven winners of the 2019 Canada Gairdner Award, the country’s highest scientific prize.

B. Frank Gupton – The Medicines for All Institute 

Floyd D Gottwald Chair of Pharmaceutical Engineering, Department Chair – Chemical and Life Science Engineering, Virginia Commonwealth University





Donna Huryn

Professor, Pharmaceutical Sciences, University of Pittsburgh

Talk: “Development of Novel Inhibitors of the AAA ATPase p97 to Interrogate Novel Biology and Fuel Drug Discovery”

Judy Leopold

Co-Director, Experimental Therapeutics Program, University of Michigan Comprehensive Cancer Center

Talk: “Precision Polypharmacology: A Rational Design Approach to Cancer Drug Resistance”

Symposium Agenda



Hotel Roanoke